Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CLELAND

Showing results (431-440 of 663) with videos related to

Pageof 67
Sort By:
Lancet (London, England)|July 31, 1998
Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failureP J Cowburn, J G Cleland, J D McArthur, et al.
European Journal of Heart Failure|August 21, 2001
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-pointsJ G Cleland, J C Daubert, E Erdmann, et al.
European Journal of Heart Failure|April 4, 2020
Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failureSusan Stienen, João Pedro Ferreira, Bertram Pitt, et al.
The Journal of Rheumatology|March 7, 2008
Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritisHeather M James, David Gillis, Pravin Hissaria, et al.
International Journal of Cardiology|June 8, 2013
Fish oil administration in older adults with cardiovascular disease or cardiovascular risk factors: is there potential for adverse events? A systematic review of the literatureAnthony M Villani, Maria Crotty, Leslie G Cleland, et al.
Arthritis and Rheumatism|December 3, 2011
Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvementMihir D Wechalekar, Susan Lester, Susanna M Proudman, et al.
Journal of Cardiovascular Risk|June 1, 1996
The concept of cardioreparation: Part 2. Medical implications of cardioreparationJ G Cleland, N G Dewhurst, R L Murphy, et al.
International Journal of Cardiology|March 15, 2000
The carvedilol hibernation reversible ischaemia trial, marker of success (CHRISTMAS) study. Methodology of a randomised, placebo controlled, multicentre study of carvedilol in hibernation and heart failureD J Pennell, S G Ray, G Davies, et al.
International Journal of Rheumatic Diseases|September 28, 2017
Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapyNasir Wabe, Jessica Wojciechowski, Mihir D Wechalekar, et al.
European Journal of Heart Failure|December 12, 2001
Validation of an echocardiographic wall motion index in heart failure due to ischaemic heart diseaseJ H McGowan, W Martin, M I Burgess, et al.
Pageof 67

Showing results (431-440 of 663) with videos related to

Sort By:
Pageof 67
Lancet (London, England)|July 31, 1998
Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failureP J Cowburn, J G Cleland, J D McArthur, et al.
European Journal of Heart Failure|August 21, 2001
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-pointsJ G Cleland, J C Daubert, E Erdmann, et al.
European Journal of Heart Failure|April 4, 2020
Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failureSusan Stienen, João Pedro Ferreira, Bertram Pitt, et al.
The Journal of Rheumatology|March 7, 2008
Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritisHeather M James, David Gillis, Pravin Hissaria, et al.
International Journal of Cardiology|June 8, 2013
Fish oil administration in older adults with cardiovascular disease or cardiovascular risk factors: is there potential for adverse events? A systematic review of the literatureAnthony M Villani, Maria Crotty, Leslie G Cleland, et al.
Arthritis and Rheumatism|December 3, 2011
Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvementMihir D Wechalekar, Susan Lester, Susanna M Proudman, et al.
Journal of Cardiovascular Risk|June 1, 1996
The concept of cardioreparation: Part 2. Medical implications of cardioreparationJ G Cleland, N G Dewhurst, R L Murphy, et al.
International Journal of Cardiology|March 15, 2000
The carvedilol hibernation reversible ischaemia trial, marker of success (CHRISTMAS) study. Methodology of a randomised, placebo controlled, multicentre study of carvedilol in hibernation and heart failureD J Pennell, S G Ray, G Davies, et al.
International Journal of Rheumatic Diseases|September 28, 2017
Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapyNasir Wabe, Jessica Wojciechowski, Mihir D Wechalekar, et al.
European Journal of Heart Failure|December 12, 2001
Validation of an echocardiographic wall motion index in heart failure due to ischaemic heart diseaseJ H McGowan, W Martin, M I Burgess, et al.
Pageof 67